Contacts
Investor Contact:
Greg Chodaczek
347-620-7010
investor@korumedical.com
KORU Medical Systems (NASDAQ:KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients, today announced that the Company will participate in Piper Sandler’s 35th Annual Healthcare Conference on November 29, 2023.
KORU Medical’s management is scheduled to present at Piper Sandler’s 35th Annual Healthcare Conference on November 29, 2023, at 1:30 pm ET. Interested parties can access the live and archived webcast on the News/Events page of the Investors section of KORU Medical’s website at www.korumedical.com.
About KORU Medical Systems
KORU Medical Systems develops, manufactures, and commercializes innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are used for infusions administered in the home and alternate care settings. For more information, please visit www.korumedical.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231129540472/en/
Related news for (KRMD)
- KORU Medical Systems Announces Agreement for Next-Generation Subcutaneous Immunoglobulin Infusion System
- KORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results; Achieves Record Full Year and Quarterly Revenues; Positive Cash Flow for the Fourth Quarter
- KORU Medical Systems, Inc. Announces 2024 Q3 Financial Results, Third Consecutive Quarter of Double-Digit Growth; Raises Full Year 2024 Guidance
- koru medical systems presents data at partnership opportunities in drug delivery (podd) conference demonstrating nursing preference for use of koru freedomedge® infusion system over manual syringe administration for subcutaneous oncology infusion